Gemphire Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
LIVONIA, Mich., March 29, 2017 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), today announced that on March 28, 2017, the Compensation Committee of its Board of Directors, which is composed entirely of independent directors, approved an …